Keywords
Abstract
Allergic diseases are among the prevalent chronic conditions worldwide, including in Uzbekistan. Syrup‐form allergy medications are widely used because they are easy to administer and particularly convenient for children. This study aims to conduct a comparative analysis of the pharmacotherapeutic efficacy of syrup allergy medicines available in Uzbekistan. It is based on clinical trials, pharmacokinetic and pharmacodynamic studies, retrospective observational studies, and pharmacoeconomic analyses. The findings serve to improve treatment effectiveness in Uzbekistan and provide scientific grounding for pharmaceutical policy development.
References
World Health Organization. Essential Medicines and Health Products Information Portal. 2023.
2. Ministry of Health of the Republic of Uzbekistan. National Drug Register, 2023.
3. Smith J., Patel R. Comparative efficacy of antihistamines: A systematic review. J Allergy Clin Immunol. 2022;150(3):567‑579.
4. Johnson M., Lee T. Pharmacokinetic profiles of anti‑allergic drugs in pediatric syrups. Pharm Res. 2021;38(11):1202‑1214.
5. Karimov B., Tursunov S. Pharmacoeconomics of allergy treatment in Central Asia. Central Asian J Pharm. 2020;5(2):34‑45.
6. European Medicines Agency. Guideline on clinical investigation of medicinal products for treatment of allergic rhinitis. 2022.
7. Lee A., Wong C. Clinical considerations in choosing antihistamine therapies. Int J Clin Pharm. 2019;41(2):301‑309.
8. Uzbek Journal of Pharmacology. Analysis of antihistamine syrup preparations in Uzbekistan. 2023.
9. Global Allergy and Asthma Patient Platform (GAAPP). Patient preferences in allergy treatments. 2022.
10. Kumar P., Singh R. Cost‑effectiveness of anti‑allergic drugs: A meta‑analysis. Health Econ Rev. 2021;11(1):20.